Key Events This Week
15 Sep: Intraday low hit amid sharp 8.07% decline
16 Sep: Technical momentum shifts to mildly bullish despite price drop
18 Sep: Technical indicators upgrade to bullish with mixed returns
Week Close: Rs.249.35, down 5.30% vs Sensex -0.41%

Indoco Remedies Ltd Technical Momentum Shifts Signal Bullish Outlook Amid Mixed Returns
2026-09-18 08:02:33Indoco Remedies Ltd has witnessed a notable shift in its technical momentum, moving from a mildly bullish to a bullish trend, signalling potential positive price action despite its mixed historical returns and a recent downgrade in its Mojo Grade to Sell. This analysis delves into the key technical indicators shaping the stock’s outlook and contextualises its performance against broader market benchmarks.
Read full news article
Indoco Remedies Ltd Technical Momentum Shifts Amid Mixed Market Signals
2026-09-16 08:05:09Indoco Remedies Ltd has experienced a notable shift in its technical momentum, moving from a bullish to a mildly bullish trend as of mid-September 2026. Despite a sharp day decline of 8.07%, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators. This analysis delves into the recent technical parameter changes, placing them in the context of the company’s price action and broader market performance.
Read full news article
Indoco Remedies Ltd Hits Intraday Low Amid Price Pressure on 15 Sep 2026
2026-09-15 13:16:29Indoco Remedies Ltd experienced a notable decline today, touching an intraday low of Rs 244, reflecting a sharp price correction of 7.33% amid heightened volatility and broader market pressures. The stock underperformed its sector and the benchmark Sensex, signalling immediate selling pressure and cautious market sentiment.
Read full news articleIndoco Remedies Gains 0.48%: 4 Key Factors Driving the Week’s Volatility
2026-09-12 15:05:05
Key Events This Week
7 Sep: Stock declines 4.14% amid broader market weakness
8 Sep: Technical momentum shifts amid mixed market returns
9 Sep: Valuation metrics signal renewed price attractiveness
10 Sep: Intraday high with strong 8.72% surge
11 Sep: Technical momentum improves with 9.88% daily gain

Indoco Remedies Ltd is Rated Sell
2026-09-11 10:10:05Indoco Remedies Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 28 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 September 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read full news articleAnnouncement under Regulation 30 (LODR)-Acquisition
18-Sep-2026 | Source : BSEPursuant to Regulation 30 of SEBI LODR the Committee of Executive Directors in its meeting held today i.e. 18th September 2026 has considered and approved the incorporation of the wholly owned subsidiary Warren Lifesciences Private Limited. The said company shall be incorporated in due course.
Shareholder Meeting / Postal Ballot-Scrutinizers Report
18-Sep-2026 | Source : BSEPlease find enclosed herewith the details of Voting Results and Scrutinizers Report for the 79th AGM of the Company held on 17th September 2026
Shareholder Meeting / Postal Ballot-Outcome of AGM
17-Sep-2026 | Source : BSEWe are submitting herewith the details regarding the Proceedings of the 79th AGM of the Company held on Thursday 17th September 2026 at 10.30 am through video conferencing(VC)/other audio video means (OAVM)
Corporate Actions
No Upcoming Board Meetings
Indoco Remedies Ltd has declared 10% dividend, ex-date: 10 Sep 26
Indoco Remedies Ltd has announced 2:10 stock split, ex-date: 17 May 12
Indoco Remedies Ltd has announced 1:2 bonus issue, ex-date: 17 May 12
No Rights history available









